Bridgeway Capital Management, LLC Tricida, Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$7.31 - $11.85 $445,698 - $722,506
-60,971 Reduced 43.77%
78,329 $758,000
Q4 2021

Feb 14, 2022
SELL
$4.19 - $9.56 $209,500 - $478,000
-50,000 Reduced 26.41%
139,300 $1.33 Million
Q3 2021

Nov 15, 2021
BUY
$3.56 - $4.64 $388,040 - $505,759
109,000 Added 135.74%
189,300 $878,000
Q2 2021

Aug 16, 2021
BUY
$3.95 - $5.41 $227,125 - $311,075
57,500 Added 252.19%
80,300 $347,000
Q1 2021

May 17, 2021
BUY
$4.52 - $7.8 $103,055 - $177,840
22,800 New
22,800 $121,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email